UiPath (PATH) Intrinsic Value Calculator

Updated: Nov 16, 2026

UiPath (PATH) trades at $13.24, close to its base-case intrinsic value of $12.69 (-4%). The model starts from $0.76 in expected earnings per share, grows it at 13.4% annually (analyst consensus) decaying to a 4% terminal rate by Year 5, applies a 17.7x exit multiple, and discounts the result back at 10% per year. The stock looks roughly fairly priced under these assumptions — the sliders below show how sensitive that conclusion is to growth and discount-rate changes.

Overvalued by 4.2%
Current Price
$13.25
Intrinsic Value
$12.69
Implied Upside: -4.2%

Discounted Cash Flow with Growth Decay Model

Customize Your Valuation

Adjust the assumptions below to model different scenarios. The intrinsic value updates in real-time.

Conservative
Base Case
Aggressive
Time Horizon 5 years
3 years 10 years
Initial Growth Rate 13.4%
0% (No Growth) 50% (High Growth)
Terminal Growth Rate 4.0%
0% (Decline) 6% (GDP+)
Discount Rate (Required Return) 10.0%
5% (Low Risk) 15% (High Risk)
Exit PE Multiple 17.7x
8x (Value) 40x (Growth)
Calculated Intrinsic Value
$12.69
--
Tradestie Long-Horizon Cycle Intelligence (2020–2026 • Split-Invariant)

Tradestie Long-Horizon Financial Resilience & Peer Growth Benchmark (7-Year Cycle Analysis)

Outside-View Peer Growth Benchmark Services-Prepackaged Software • 2498+ US Equities Benchmarked

Across 19 years of multi-cycle financial history in Services-Prepackaged Software, only 51.0% of peer companies at >$1B revenue scale (853 historical 5-year windows; industry median CAGR: 8.2%/yr) sustained ≥8%/yr 5-year compound revenue growth (broad >$1B equity base rate: 33.2%).

≥5%/yr (5Y)
66.1%
All >$1B: 50.1%
≥10%/yr (5Y)
39.7%
All >$1B: 24.5%
≥15%/yr (5Y)
21.9%
All >$1B: 12.2%
≥20%/yr (5Y)
12.9%
All >$1B: 6.8%
≥25%/yr (5Y)
8.9%
All >$1B: 4.2%
≥30%/yr (5Y)
5.7%
All >$1B: 2.4%
Sector Revenue Pool (iShares Expanded Tech-Software ETF): Market-implied 5Y revenue CAGR for PATH is 24.3%/yr vs faded consensus anchor of 8.6%/yr (pool implied: 53.2%/yr).
7-Yr Revenue Scale
$336M → $1.61B
6Y CAGR: +29.8%/yr • 5Y: +21.5%
2008–2009 Cycle Trough Floor
Post-2009 Series
Tracked from FY2020
2022 Rate-Shock Floor
-32.9% Op Margin
FY2023 Rev: $1.06B (+18.6% YoY)
Latest vs Cycle Median Margin
3.5% vs -18.2% med
Cyclical Margin Profile — Stress-Test Exit Multiples
Multi-Cycle Revenue & Operating Margin Trajectory (2020–2026) Expansion 2008–09 / 2022 Macro Stress
-154%
'20
-18%
'21
-56%
'22
-33%
'23
-13%
'24
-11%
'25
4%
'26
Inspect All 7 Fiscal Years of Annual Revenue & Operating Margin History Toggle Annual Ledger ↓
Fiscal Year Annual Revenue YoY Growth Operating Income Operating Margin Macro Cycle Regime
FY2026 (2026-01) $1.61B +12.7% $57M 3.5% Standard
FY2025 (2025-01) $1.43B +9.3% -$163M -11.4% Standard
FY2024 (2024-01) $1.31B +23.6% -$165M -12.6% Standard
FY2023 (2023-01) $1.06B +18.6% -$348M -32.9% 2022 Rate Shock
FY2022 (2022-01) $892M +46.8% -$501M -56.1% Standard
FY2021 (2021-01) $608M +80.8% -$110M -18.2% Standard
FY2020 (2020-01) $336M — -$517M -153.9% Standard

Year-by-Year Projections

EPS growth decays from initial rate to terminal rate over the projection period.

Year Growth Rate EPS Stock Price Present Value

Price Projection

Sensitivity Analysis

How intrinsic value changes with different growth and discount rate assumptions.

Model Inputs
Base EPS $0.76
Current Price $13.25
Historical PE 17.7x
Analyst Growth Est. 13.4%
How It Works

Growth Decay Model: We project EPS growth that gradually slows from the initial rate to a terminal rate (typically 3-4%, matching long-term GDP growth).

Terminal Value: At the end of the projection period, we apply an exit PE multiple to estimate the future stock price.

Discounting: Future values are discounted back to today using your required rate of return (discount rate).